Read + Share
Amedeo Smart
Independent Medical Education
Evans CD, Sims JR. Use of Donanemab in Early Symptomatic Alzheimer Disease-Reply. JAMA 2023;330:2304-2305.PMID: 38112817
Email
LinkedIn
Facebook
Twitter
Privacy Policy